Lifeward Ltd. (LFWD)
NASDAQ: LFWD · Real-Time Price · USD
7.00
-0.08 (-1.13%)
At close: May 5, 2026, 4:00 PM EDT
7.00
0.00 (0.00%)
Pre-market: May 6, 2026, 8:22 AM EDT
Lifeward Revenue
In the year 2025, Lifeward had annual revenue of $22.03M, down -14.14%. Lifeward had revenue of $5.08M in the quarter ending December 31, 2025, a decrease of -32.66%.
Revenue (ttm)
$22.03M
Revenue Growth
-14.14%
P/S Ratio
0.88
Revenue / Employee
$272,025
Employees
81
Market Cap
19.45M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 22.03M | -3.63M | -14.14% |
| Dec 31, 2024 | 25.66M | 11.81M | 85.24% |
| Dec 31, 2023 | 13.85M | 8.34M | 151.39% |
| Dec 31, 2022 | 5.51M | -455.00K | -7.63% |
| Dec 31, 2021 | 5.97M | 1.57M | 35.81% |
| Dec 31, 2020 | 4.39M | -480.00K | -9.85% |
| Dec 31, 2019 | 4.87M | -1.67M | -25.55% |
| Dec 31, 2018 | 6.55M | -1.21M | -15.58% |
| Dec 31, 2017 | 7.75M | 1.88M | 32.10% |
| Dec 31, 2016 | 5.87M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nortech Systems | 118.37M |
| IRIDEX | 52.68M |
| Trinity Biotech | 43.79M |
| Myomo | 40.93M |
| Pulsenmore | 12.55M |
| Picard Medical | 4.94M |
| IceCure Medical | 3.38M |
| VolitionRx | 1.73M |
LFWD News
- 2 days ago - Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton - GlobeNewsWire
- 5 weeks ago - Lifeward Successfully Closes on Strategic Partnership with Oramed - GlobeNewsWire
- 7 weeks ago - Lifeward Earnings Call Transcript: Q4 2025 - Transcripts
- 7 weeks ago - Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 7 weeks ago - Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company - GlobeNewsWire
- 2 months ago - Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 2 months ago - Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026 - GlobeNewsWire
- 2 months ago - Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton - GlobeNewsWire